treatment of acute mania in pediatric bipolar disorder assessing the evidence stewart s. newman md...
Post on 20-Dec-2015
217 views
TRANSCRIPT
Treatment of Acute Mania in Pediatric Bipolar Disorder
Assessing the Evidence
Stewart S. Newman MD
Senior Child Fellow
2
Discussion Case
16 y/o WF with hx of bipolar disorder presents to the PES in the custody of AA police
Reportedly was in a physical altercation with a fellow student at Pioneer HS
Police indicate she was combative and belligerent towards them upon initial contact
3
Discussion Case, cont’d
Patient is followed by a Child Fellow in the Commonwealth outpatient clinic
Previously treated with divalproex and risperidone in combination
Records indicate she has missed her last three appointments, and her medication supply should have been exhausted two months ago
4
Discussion Case, cont’d
Per the outpatient treatment notes, the patient has been hospitalized once previously for suicidal ideation
The patient has a history of intermittent cannabis and alcohol abuse
There is a family history of bipolar disorder in a paternal grandfather
5
Discussion Case, cont’d
On initial assessment, she is hyperverbal, giddy and expansive, but can rapidly become angry and belligerent with staff
She is unable to give an account of the altercation at school, simply stating “The bitch deserved it.”
6
Discussion Case, cont’d
Tells the evaluator repeatedly “You don’t want to do this, you know I’m too important to be put through this.”
When stopped by the police officer from leaving PES, she begins to make sexualized comments towards him regarding being “handcuffed”
7
Discussion Case, cont’d
The patient becomes combative with staff members, tries to elope and Security responds to PES
The patient is placed in the seclusion suite due to elopement risk
She is refusing any medication to calm her or organize her thoughts
8
“The Question”
“What evidence do we have to guide the treatment of acute mania in pediatric
bipolar disorder?”
9
Levels of EvidenceLevel A: systematic review of RCTs with
narrow confidence intervalsLevel B: systematic review of cohort
studies with homogeneity, individual cohort study, or low quality RCT outcomes studies
Level C: systematic review of case-control studies, individual case control studies, case series, and expert opinions with explicit critical appraisalAdapted from the US Preventive Services Task
Force 1996
10
Searching the Literature
Online resources onlySearches on Medline, EMBase,
Cochrane, Up To Date, MD Consult, AACAP Website
Used keyword searches:Pediatric bipolar disorderPediatric maniaAcute mania treatment
11
Selected Articles
M. N. Pavuluri et. al. “A Pharmacotherapy Algorithm for Stabilization and Maintenance of Pediatric Bipolar Disorder” JAACAP 43:7, July 2004
M. Bourin, O. Lambert and B. Guitton “Treatment of Acute Mania- from clinical trials to recommendations for clinical practice” Human Psychopharmacology 20, 2005
J. McClellan and J. Werry “AACAP Practice Parameters for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder” JAACAP 1997
12
Pavuluri et. al. 2004
Developed and studied a treatment algorithm for stabilization and maintenance of pediatric bipolar disorder
Two phases of treatment- goal of the first phase was mood stabilization
Discussed evidence used for development of the algorithm
13
Pavuluri et. al. 2004
14
Pavuluri et. al. 2004
Noted Level B studies in children indicate mood stabilizers as the primary agents
Lithium or divalproex as first line agents, followed by carbamazepine
15
Pavuluri et. al. 2004
Good evidence for addition of atypical antipsychotic agent for more severe or psychotic mania cases
Atypical antipsychotic agent monotherapy first line for predominant irritability or aggression
16
Pavuluri et. al. 2004
Positives:Specific to the pediatric populationDevelopment of treatment algorithmDiscussion of level of evidence used
Negatives:Treatment not specific to acute maniaUse of three mood stabilizers, four
atypical antipsychotics
17
Bourin et. al. 2005
Review of the literature regarding treatment of acute mania
Highlights the conceptual differences between the US and Europe
18
Bourin et. al. 2005
Discusses individual medications (mood stabilizers, antipsychotics, and benzodiazepines) alone and in combinations
Also discusses efficacy of certain agents, forms of mania that predict treatment response, and alternate agent choices in a systematic manner
19
Bourin et. al. 2005
Recommends first line use of mood stabilizers lithium and divalproate, with carbamazepine as second line
Also recommends use of atypical antipsychotics as monotherapy or adjunct to mood stabilizer treatment
Discussed use of “third gen” anticonvulsants in detail
20
Bourin et. al. 2005
Positives:Specific to treatment of acute maniaDiscusses available evidence in a
systematic fashionRecent review of the literature
Negatives:Not specific to childrenEmphasis on US vs Europe
21
McClellan, Werry 1997
“Practice Parameters” series represent exhaustive review of the available literature and expert concensus
Specific section regarding treatment of acute manic symptoms
Explicitly discusses rationale for choice of medication
22
McClellan, Werry 1997
Recommend mood stabilizers (lithium and divalproex) as first line agents
Carbamazepine recommended as second line mood stabilizer
Adjunctive treatment with atypical antipsychotics or benzodiazepines may be necessary
23
McClellan, Werry 1997
Positives:Focused on treatment of childrenSection on acute mania treatment Authority that establishes “standard of
care”
Negatives:38 pages long!Dated literature review with no recent
update available
24
Conclusions
First line treatment for acute mania in children and adolescentsMood stabilizer: lithium or divalproexConsider carbamazepine second
Consideration of adjunctive treatmentAtypical antipsychotics, especially in
mania with psychosis or agitationPossibly antipsychotic monotherapy